MedTrace Logo

Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

NCT03354026 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2017-11-27

No results posted yet for this study

Summary

The purpose of this research is to use the "Removing Blood Stasis Decotion" of traditional Chinese medicine treating the acute stage of cerebral hemorrhage with stroke associated pneumonia to explore the impact of "Removing Blood Stasis Therapy" on intestinal microbial flora either within the time window from 6 to 72 hours onset.

Conditions

  • Intracerebral Hemorrhage, Hypertensive
  • Traditional Chinese Medicine

Interventions

DRUG

AICH-PXZY

8herbals (with 2 herbals of Activating blood stagnation and expelling blood stasis herbs) one dose, bid, for 10 days

DRUG

AICH-without PXZY

AICH-2(herbal medicine without Hirudo, Tabanus) (6herbals, without 2 herbals of promoting blood stasis) one dose, bid, for 10 days

DRUG

AICH-placebo

The placebo is made up of Starch, bitter taste and cyclodextrin

Sponsors & Collaborators

  • Lianjiang people's Hospital

    collaborator UNKNOWN

  • Shenyang Second Hospital of traditional Chinese Medicine

    collaborator UNKNOWN

  • The Third People's Hospital of Hubei Province

    collaborator OTHER

  • Liaocheng People's Hospital

    collaborator OTHER

  • Zengcheng Hospital of traditional Chinese Medicine

    collaborator UNKNOWN

  • Shouguang people's Hospital

    collaborator UNKNOWN

  • Guangzhou University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03354026 on ClinicalTrials.gov